Ensoma completes purchase of Danish CRISPR firm
Twelve Bio, a company researching ways to improve CRISPR technology within diagnostics and treatment, is now formally part of US biotech company Ensoma.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Ensoma acquires Danish CRISPR university spin-off
For subscribers
Novo Holdings invests in US-based gene-editing company
For subscribers